MN 553 UNIT 5 QUIZ | QUESTIONS WITH ANSWERS 2023/2024 | VERIFIED ANSWERS
MN 553 UNIT 5 QUIZ | QUESTIONS WITH ANSWERS 2023/2024 | VERIFIED ANSWERS. Sulfonylureas may be added to a treatment regimen for type 2 diabetics when lifestyle modifications and metformin are insufficient to achieve target glucose levels. Sulfonylureas have been moved to Step 2 therapy because they: Question options: Increase endogenous insulin secretion Have a significant risk for hypoglycemia Address the insulin resistance found in type 2 diabetics Improve insulin binding to receptors Question 6 Treatment with insulin for type 1 diabetics: Question options: Starts with a total daily dose of 0.2 to 0.4 units per kg of body weight Divides the total doses into three injections based on meal size Uses a total daily dose of insulin glargine given once daily with no other insulin required Is based on the level of blood glucose Question 7 The American Heart Association states that people with diabetes have a 2- to 4-fold increase in the risk of dying from cardiovascular disease. Treatments and targets that do not appear to decrease risk for micro- and macro-vascular complications include:
Written for
- Institution
-
Kaplan University
- Course
-
MN 553 Advanced Pharmacology
Document information
- Uploaded on
- July 10, 2023
- Number of pages
- 7
- Written in
- 2022/2023
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
- mn 553
- advanced pharmacology
- mn 553 unit 5 quiz
- dizziness
- confusio
-
mn
-
mn 553 advanced pharmacology
-
mn 553 unit 5 quiz | questions with answers 2023
-
decreases glycogenolysis by the liver
-
hypoglycemia
Document also available in package deal